Pharmacokinetics of meloxicam in rabbits after oral administration of single and multiple doses
- 1 April 2013
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 74 (4), 636-641
- https://doi.org/10.2460/ajvr.74.4.636
Abstract
Objective—To determine the pharmacokinetics of meloxicam (1 mg/kg) in rabbits after oral administration of single and multiple doses. Animals—6 healthy rabbits. Procedures—A single dose of meloxicam (1 mg/kg, PO) was administered to the rabbits. After a 10-day washout period, meloxicam (1 mg/kg, PO) was administered to rabbits every 24 hours for 5 days. Blood samples were obtained from rabbits at predetermined intervals during both treatment periods. Plasma meloxicam concentrations were determined, and noncompartmental pharmacokinetic analysis was performed. Results—The mean peak plasma concentration and area under the plasma concentration-versus-time curve extrapolated to infinity after administration of a single dose of meloxicam were 0.83 μg/mL and 10.37 h•μg/mL, respectively. After administration of meloxicam for 5 days, the mean peak plasma concentration was 1.33 μg/mL, and the area under the plasma concentration-versus-time curve from the time of administration of the last dose to 24 hours after that time was 18.79 h•μg/mL. For single- and multiple-dose meloxicam experiments, the mean time to maximum plasma concentration was 6.5 and 5.8 hours and the mean terminal half-life was 6.1 and 6.7 hours, respectively. Conclusions and Clinical Relevance—Plasma concentrations of meloxicam for rabbits in the present study were proportionally higher than those previously reported for rabbits receiving 0.2 mg of meloxicam/kg and were similar to those determined for animals of other species that received clinically effective doses. A dose of 1 mg/kg may be necessary to achieve clinically effective circulating concentrations of meloxicam in rabbits, although further studies are needed.Keywords
This publication has 15 references indexed in Scilit:
- Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogsAmerican Journal of Veterinary Research, 2011
- Single and Multiple-Dose Pharmacokinetics of Meloxicam After Oral Administration to the Rabbit (Oryctolagus cuniculus)Journal of Zoo and Wildlife Medicine, 2009
- Meloxicam: a reappraisal of pharmacokinetics, efficacy and safetyExpert Opinion on Pharmacotherapy, 2005
- Clinical Approaches to Analgesia in Ferrets and RabbitsSeminars in Avian and Exotic Pet Medicine, 2005
- Nonsteroidal Antiinflammatory Drugs: A ReviewJournal of the American Animal Hospital Association, 2005
- In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogsAmerican Journal of Veterinary Research, 2002
- Safety and efficacy of preoperative administration of meloxicam, compared with that of ketoprofen and butorphanol in dogs undergoing abdominal surgeryAmerican Journal of Veterinary Research, 2001
- Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and catsJournal of the American Veterinary Medical Association, 2000
- Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor?American Journal Of Medicine, 1997
- A comparison of the postoperative analgesic and sedative effects of flimixin and pap aver etum in the dogJournal of Small Animal Practice, 1991